MPWT
IRWD icon

MassMutual Private Wealth & Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-350
Closed -$1.55K – 2417
2024
Q4 		$1.55K Buy
350
+306
+695% +$1.24K ﹤0.01% 1904
2024
Q3 		$181 Sell
44
-28
-39% -$151 ﹤0.01% 2098
2024
Q2 		$469 Sell
72
-2
-3% -$14 ﹤0.01% 1965
2024
Q1 		$645 Sell
74
-66
-47% -$801 ﹤0.01% 1809
2023
Q4 		$1.6K Buy
140
+79
+130% +$781 ﹤0.01% 1577
2023
Q3 		$587 Sell
61
-2,079
-97% -$20.4K ﹤0.01% 1791
2023
Q2 		$22.8K Buy
2,140
+1,900
+792% +$20.4K ﹤0.01% 734
2023
Q1 		$2.52K Buy
240
+125
+109% +$1.4K ﹤0.01% 1345
2022
Q4 		$1K Buy
115
+18
+19% +$204 ﹤0.01% 1471
2022
Q3 		$1K Buy
+97
New +$1.1K ﹤0.01% 1449
2022
Q1 		– Sell
-59
Closed -$1K – 1576
2021
Q4 		$1K Buy
59
+20
+51% +$245 ﹤0.01% 1241
2021
Q3 		$1K Hold
39
– – ﹤0.01% 1181
2021
Q2 		$1K Hold
39
– – ﹤0.01% 1140
2021
Q1 		$0 Buy
+39
New +$412 ﹤0.01% 1143

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MassMutual Private Wealth & Trust's IRWD Position: Q1 2025 in Review

MassMutual Private Wealth & Trust sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 350 shares — an estimated $1.55K sold.

MassMutual Private Wealth & Trust first reported a position in IRWD in Q1 2021 and held it in 14 quarters. The position peaked at $22.8K in Q2 2023. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • MassMutual Private Wealth & Trust reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 350 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $1.55K.
  • MassMutual Private Wealth & Trust first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 14 quarters.
  • MassMutual Private Wealth & Trust's Ironwood Pharmaceuticals position peaked at $22.8K in Q2 2023.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.